(AGENPARL) – SILVER SPRING mar 02 maggio 2023 The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products…

(AGENPARL) – SILVER SPRING gio 27 aprile 2023 The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and…

(AGENPARL) – gio 27 aprile 2023 Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy…

(AGENPARL) – SILVER SPRING mar 25 aprile 2023 FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated…

(AGENPARL) – BRISTOL (UK) mar 25 aprile 2023 A gene in the brain driving anxiety symptoms has been identified by…

(AGENPARL) – SILVER SPRING ven 21 aprile 2023 This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3,…

(AGENPARL) – STATE COLLEGE ven 21 aprile 2023 New insight into proteins called “pioneer factors” helps to explain their unusual ability…

(AGENPARL) – SILVER SPRING mer 19 aprile 2023 This is the main page for the 2017 Meeting Materials, Cellular, Tissue and…

(AGENPARL) – SILVER SPRING mer 19 aprile 2023 This is the CBER Cellular, Tissue and Gene Therapies Advisory Committee October 12,…

(AGENPARL) – SILVER SPRING mar 11 aprile 2023 This is the main landing page for the CBER Cellular, Tissue, and Gene…